e.g. mhealth
Search Results (1 to 10 of 28 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 11 JMIR Diabetes
- 4 JMIR Medical Informatics
- 4 JMIR Research Protocols
- 3 JMIR Formative Research
- 3 JMIR Human Factors
- 2 Journal of Medical Internet Research
- 1 JMIR Nursing
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

In both cases, glucose monitoring is necessary [3] to prevent or treat acute (hypoglycemia, hyperglycemia, and diabetic ketoacidosis [DKA]) or chronic (microvacular and macrovascular) complications, and more frequent monitoring has been shown to have better diabetes outcomes [4].
JMIR Form Res 2025;9:e64585
Download Citation: END BibTex RIS

Although the pathogenic mechanisms of T1 DM and T2 DM are different, glucose-lowering treatments such as insulin administration are the common leading cause of hypoglycemia events in patients with both diabetes subtypes [4]. Severe hypoglycemia is a frequent phenomenon in patients with T1 DM, with an annual prevalence of 30%-40% [5].
JMIR Med Inform 2024;12:e56909
Download Citation: END BibTex RIS

One of the most relevant acute complications associated with T1 DM is hypoglycemia (ie, low blood glucose). This condition is associated with impaired cognitive, executive, and psychomotor function [2-4] and is linked to driving mishaps [5-7].
Previous work introduced the development of a voice warning for hypoglycemia while behind the wheel, whereas the voice assistant (VA) would work as a warning interface [8].
JMIR Hum Factors 2024;11:e46967
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section

Hypoglycemia, also known as low blood glucose, is a frequent and acute complication in patients with T1 DM [2,3]. Symptoms range from autonomic reactions such as trembling, anxiety, and hunger (ie, mild hypoglycemia) to neuroglycopenic reactions such as vision impairment, weakness, or cognitive impairments (ie, severe hypoglycemia) [2,4-6]. Hypoglycemia is a major issue in the context of driving: research has shown that hypoglycemia is associated with a higher risk of car mishaps [7-9].
JMIR Hum Factors 2024;11:e42823
Download Citation: END BibTex RIS

Adverse blood glucose (BG) events are one of the most common short-term complications, including hypoglycemia with BG180 mg/d L. Hyperglycemia in patients with DM may lead to lower limb occlusions and extremity nerve damage, further leading to decay, necrosis, and local or whole-foot gangrene, even requiring amputation [8,9]. Hypoglycemia can cause serious symptoms, including anxiety, palpitation, and confusion in a mild scenario and seizures, coma, and even death in a severe scenario [10,11].
JMIR Med Inform 2023;11:e47833
Download Citation: END BibTex RIS

Unhelpful hypoglycemia beliefs that can contribute to poor self-management include the following: minimal hypoglycemia risk perceptions; high perceptions of hyperglycemia and social risks from hypoglycemia self-management (which can lead to low hypoglycemia self-management outcome expectancies); and low hypoglycemia management coping efficacy [33,39,40].
JMIR Form Res 2023;7:e50374
Download Citation: END BibTex RIS

Hypoglycemia, or low blood glucose, is a common complication of insulin treatment among people with type 1 diabetes mellitus (T1 DM) and insulin-treated type 2 diabetes mellitus (T2 DM). Hypoglycemia can result in neurocognitive impairment [1] and can be debilitating, adversely affecting multiple aspects of quality of life (eg, work life and relationships) for people with diabetes and their family members [2-4].
JMIR Diabetes 2023;8:e42100
Download Citation: END BibTex RIS

The current American Diabetes Association (ADA) and International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines recommend the therapeutic goal of glycated hemoglobin (Hb A1c)
With recent advances over the last few years, such as better safety profiles in insulin pharmacokinetics and new diabetes devices, the risk of hypoglycemia has been reduced, and patients have been able to achieve better Hb A1c goals [7-12].
JMIR Diabetes 2023;8:e46880
Download Citation: END BibTex RIS

Older adults living with T1 D often experience age-related changes including increasing hypoglycemia accompanied by hypoglycemia unawareness [4]. Severe hypoglycemia in older adults can lead to loss of consciousness, seizures, falls, and other complications such as myocardial infarction [5-7]. However, technology such as continuous glucose monitoring (CGM) has recently been shown to be effective in reducing hypoglycemia and hyperglycemia in older adults with T1 D [8,9].
JMIR Nursing 2023;6:e46627
Download Citation: END BibTex RIS